Three women with lupus transverse myelitis: Case reports and differential diagnosis

Archives of Physical Medicine and Rehabilitation

Volumn 79, Issue 4, 1998, Pages 456-459

  Inslicht, David V ^a   Stein, Adam B ^a   Pomerantz, Ferne ^a   Ragnarsson, Kristjan T ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; PREDNISONE;

ADULT; ARTICLE; CASE REPORT; CORTICOSTEROID THERAPY; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; LUPUS ERYTHEMATOSUS; MYELITIS; NEUROLOGICAL COMPLICATION; NUCLEAR MAGNETIC RESONANCE IMAGING; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0031900098     PISSN: 00039993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-9993(98)90150-2     Document Type: Article

References (19)

1. Wallace DJ, Metzger AL. Systemic lupus erythematosus and the nervous system. In: Wallace DJ, Hahn BH, editors. Dubois' lupus erythematosus. 4th ed. Philadelphia: Lea & Febiger; 1993. p. 370-85.
2. Francis GS, Antel JP, Duquette P. Inflammatory demyelinating diseases of the central nervous system. In: Bradley WG, Daroff RB, Fenichel GM, editors. Neurology in clinical practice. Boston (MA): Butterworth-Heineman; 1991. p. 1162.
3. Penn AS, Rowan AJ. Myelopathy in systemic lupus erythematosus. Arch Neurol 1968; 18:337-49.
4. Harisdangkul V, Doorenbos D, Subramony SH. Lupus transverse myelopathy: better outcome with early recognition and aggressive high-dose intravenous corticosteroid pulse treatment. J Neurol 1995;242:326-31.
5. Chan KF, Kong KH, Boey ML. "Great mimicry" in a patient with tetraparesis: a case report. Arch Phys Med Rehabil 1995;76:391-3.
6. Barile L, Lavalle C. Transverse myelitis in systemic lupus erythematosus - the effect of IV pulse methylprednisolone and cyclophosphamide. J Rheumatol 1992;19:370-2.
7. Klaiman MD, Miller SD. Transverse myelitis complicating systemic lupus erythematosus: treatment including hydroxychloroquine. Am J Phys Med Rehabil 1993;72:158-61.
8. Valesini G, Priori R, Francia A, Balestrieri G, Tincani A, Airo P, et al. Central nervous system involvement in systemic lupus erythematosus: a new therapeutic approach with intrathecal dexamethasone and methotrexate. Springer Semin Immunopathol 1994;16: 313-21.
9. Provenzale JM, Barboriak DP, Gaensler E, Robertson RL, Mercer B. Lupus-related myelitis: serial MR findings. Am J Neuroradiol 1994;15:1911-7.
10. Murray KM, Camp MS. Cephalexin-induced Stevens-Johnson syndrome. Ann Pharmacother 1992;26:1230-2.
11. Mok CC, Lau CS. Transverse myelopathy complicating mixed connective tissue disease. Clin Neurol Neurosurg 1995;97:259-60.
12. Mandler RN, Davis LE, Jeffrey DR, Kornfeld M. Devic's neuromyelitis optica: a clinicopathological study of 8 patients. Ann Neurol 1993;34:162-8.
13. Mendez MF, Pogacar S. Malignant monophasic multiple sclerosis or "Marburg's disease." Neurology 1988;38:1153-5.
14. Dore-Duffy P, Donaldson JO, Rothman BL, Zurier RB. Antinuclear antibodies in multiple sclerosis. Arch Neurol 1982;39: 504-6.
15. Ellenberg M. Lupoid sclerosis [letter]. Arch Phys Med Rehabil 1978;59:43-4.
16. Bluestein HG. Neuropsychiatric disorders in systemic lupus erythematosus. In: Lahita RG, editor. Systemic lupus erythematosus. New York:Wiley; 1987. p. 593-614.
17. Kaplan PE, Betts HB. Lupoid sclerosis: evaluation and treatment. Arch Phys Med Rehabil 1977;58:24-8.
18. Marullo S, Clauvel JP, Intrator L, Danon F, Brouet JC, Oksenhendler E. Lupoid sclerosis with antiphospholipid and antimyelin antibodies. J Rheumatol 1993;20:747-9.
19. Yoshio T, Masuyama J, Ikeda M, Tamai K, Hachiya T, Emori T, et al. Quantification of antiribosomal P0 protein antibodies by ELISA with recombinant P0 fusion protein and their association with central nervous system disease in systemic lupus erythematosus. J Rheumatol 1995;22:1681-7.